Interventional Cardiology Devices Market (By Product: Angioplasty Balloons, Angioplasty Stents, Angioplasty Catheters, Endovascular Aneurysm, Repair Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Accessories) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2021 – 2030
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Interventional Cardiology Devices Market
5.1. COVID-19 Landscape: Interventional Cardiology Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Interventional Cardiology Devices Market, By Product
8.1. Interventional Cardiology Devices Market, by Product Type, 2021-2030
8.1.1. Angioplasty Balloons
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Angioplasty Stents
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Angioplasty Catheters
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Endovascular Aneurysm Repair Stent Grafts
8.1.4.1. Market Revenue and Forecast (2019-2030)
8.1.5. Inferior Vena Cava (IVC) Filters
8.1.5.1. Market Revenue and Forecast (2019-2030)
8.1.6. Plaque Modification Devices
8.1.6.1. Market Revenue and Forecast (2019-2030)
8.1.7. Hemodynamic Flow Alteration Devices
8.1.7.1. Market Revenue and Forecast (2019-2030)
8.1.8. Accessories
8.1.8.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Interventional Cardiology Devices Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2019-2030)
9.1.2. U.S.
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Forecast, by Product (2019-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2019-2030)
9.2.2. UK
9.2.2.1. Market Revenue and Forecast, by Product (2019-2030)
9.2.3. France
9.2.3.1. Market Revenue and Forecast, by Product (2019-2030)
9.2.4. Rest of Europe
9.2.4.1. Market Revenue and Forecast, by Product (2019-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2019-2030)
9.3.2. India
9.3.2.1. Market Revenue and Forecast, by Product (2019-2030)
9.3.3. China
9.3.3.1. Market Revenue and Forecast, by Product (2019-2030)
9.3.4. Japan
9.3.4.1. Market Revenue and Forecast, by Product (2019-2030)
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2019-2030)
9.4.2. GCC
9.4.2.1. Market Revenue and Forecast, by Product (2019-2030)
9.4.3. North Africa
9.4.3.1. Market Revenue and Forecast, by Product (2019-2030)
9.4.4. South Africa
9.4.4.1. Market Revenue and Forecast, by Product (2019-2030)
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2019-2030)
9.5.2. Brazil
9.5.2.1. Market Revenue and Forecast, by Product (2019-2030)
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Forecast, by Product (2019-2030)
Chapter 10. Company Profiles
10.1. Boston Scientific Corporation
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Medtronic
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Edward Lifesciences Corporation
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Abbott
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. BIOTRONIK SE & Co. KG
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. iVascular
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Terumo Corporation
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. B. BarunMelsungen
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Biosensors International Group
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Cardinal Health
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample